Aileron Therapeutics, Inc.
Peptidomimetic macrocycles and formulations thereof

Last updated:

Abstract:

Aqueous pharmaceutical formulations, for parenteral administration, comprising peptidomimetic macrocycle or a pharmaceutically acceptable salt thereof wherein the peptidomimetic macrocycle binds to MDM2 and/or MDMX proteins are disclosed. Also disclosed are methods of treating diseases and disorders using the aqueous pharmaceutical formulations disclosed herein.

Status:
Grant
Type:

Utility

Filling date:

24 Sep 2015

Issue date:

2 Feb 2021